Akanocure Pharmaceuticals

Chromacure

This company develops small molecule therapeutics for oncology patients to address unmet clinical needs in cancer treatment.

ArQule

This biopharmaceutical company develops targeted small molecule drug candidates to treat cancers and rare diseases for patients with unmet medical needs.

Calithera

This pharmaceutical company develops small-molecule drugs targeting cancer metabolism and tumour immunology for healthcare providers and patients with oncology and haematology conditions.

MyCural Therapeutics

This company develops small molecule drugs targeting the MYC oncoprotein to treat patients with aggressive, high-risk cancers.

Accent Therapeutics

This biopharmaceutical company develops small molecule precision therapies for patients with various types of cancer.

Scorpion Therapeutics

This clinical-stage company develops small-molecule drugs and targeted therapies for patients with various forms of cancer.

Kinnate Biopharma

The company develops small molecule kinase inhibitors for patients with difficult-to-treat cancers featuring specific genetic alterations.

Alphina Therapeutics

This biotechnology company develops antibody-drug conjugates with novel payloads to treat solid tumours for healthcare providers and cancer patients.